Uromedica
Plymouth, US · Minnesota corporation
Uromedica is a medical device company that develops long-term implantable adjustable balloon therapy to treat male and female stress urinary incontinence, marketed as ProACT for men and ACT for women. Its urologic implants are used by patients and partnered physicians, with availability in Europe, Canada, and Australia while the female ACT system remains investigational in the US.
Founders & leadership
TH
THEODORE HERZOGNamed on SEC filing
JL
JOHN L REINECKNamed on SEC filing
TC
TIMOTHY C COOKNamed on SEC filing
DB
DAVID BOOTHNamed on SEC filing
JH
JOHN H BURTONNamed on SEC filing
DG
DOUGLAS GLADDERNamed on SEC filing
SC
STEPHEN CLARKNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$600K disclosed across 1 round · 2018
▶$600KraisedJan 2019 · 12 investors · BiotechnologyRule 506(c)
▶$600KraisedJan 2019 · 12 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- THEODORE HERZOGDirector
- JOHN L REINECKExecutive Officer
- TIMOTHY C COOKExecutive Officer, Director
- DAVID BOOTHDirector
- JOHN H BURTONExecutive Officer, Director
- DOUGLAS GLADDERDirector
- STEPHEN CLARKDirector
- Offering amount
- $4M
- Amount sold
- $600K
- Minimum investment
- $50K
- First sale
- Dec 2018
- Incorporated
- Corporation, Minnesota
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapBoston Scientific26 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Rf Surgical12 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Uclahealth11 shared keywordsUCLA Health is a major academic health system providing patient care across five hospitals and 290 clinics in Southern California and the Central Coast, alongside research and medical education. The organization conducts pioneering research in oncology, transplantation, neurosurgery, and other specialties, having contributed to the development of numerous FDA-approved treatments.
Companies competing with Uromedica for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Uromedica do?
- Uromedica is a medical device company that develops long-term implantable adjustable balloon therapy to treat male and female stress urinary incontinence, marketed as ProACT for men and ACT for women. Its urologic implants are used by patients and partnered physicians, with availability in Europe, Canada, and Australia while the female ACT system remains investigational in the US.
- How much funding has Uromedica raised?
- Uromedica has disclosed $600K raised across 1 round.
- Where is Uromedica headquartered?
- Uromedica is headquartered in Plymouth, US.